Company intelligence / Profile preview

Aerogen

Ownership: Private
Employees: ~750
Development stage: Phase 2

Overview

Aerogen's technology has been in use for over 25 years in more than 75 countries globally and is associated with over 200 clinical papers and publications[1]

Therapeutic areas: Pulmonology
Modalities: Aerosol drug delivery systems
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

AeroFact

Phase 2

Indications: Respiratory Distress Syndrome

Partnerships

Partner of choice for the world's leading ventilator companies for aerosol drug delivery[1]

Beyond the preview

Go deeper on Aerogen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aerogen.

Explore the full profile